European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

Hotline III: Late Breaking Trials on Arrhythmias and CAD

ESC Congress 2012 Press Conference

Date & Time:  Tuesday 28 August, 08:00-09:00

Topic(s):
  Arrhythmias, CAD

Chairs:Keith FOX (United Kingdom)
 David HOLMES (United States of America)

Spokespersons

Prof Miguel Sousa Uva (Portugal)Prof Robert Hatala (Slovakia)


ESC Congress 2012 in Munich
PRAGUE-12 trial: randomized open multicentre study comparing cardiac surgery with MAZE versus cardiac surgery without MAZE in patients with coronary and/or valvular heart disease and with atrial fibrillationpress release
press release
 
Petr WIDIMSKY (Czech Republic)Refers to session: Hot Line III: Late Breaking Trials on Arrhythmias and CAD presentation slides presentation slides
A multicentre study of surgical ablation (using the MAZE procedure) has assessed its long-term impact in patients with AF referred for cardiac surgery. The study tested the hypothesis that MAZE would increase sinus rhythm prevalence one year after surgery without increasing peri-procedural complications, and possibly improve the long-term clinical outcomes (mortality, heart failure, stroke, bleeding).session webcastwebcast
  congress report 



ESC Congress 2012 in Munich
WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)press release

congress news

press release
 
Willem DEWILDE 
(Netherlands)
Refers to session:  Hot Line III: Late Breaking Trials on Arrhythmias and CAD presentation slides presentation slides
The WOEST study is designed to answer a specific dilemma in cardiology: the optimal antithrombotic treatment in patients on oral anticoagulant drugs (for atrial fibrillation or mechanical valve) who have to undergo coronary stenting. The study is the first on safety of omitting aspirin in this kind of patient. session webcastwebcast
  congress report 



ESC Congress 2012 in Munich
Catheter ablation for atrial fibrillation: results from the first European registrypress release

congress news

press release
 
Elena ARBELO (Spain)Refers to session:  Hot Line III: Late Breaking Trials on Arrhythmias and CADpresentation slides presentation slides

 

The AFib Ablation Pilot Study, the first registry to evaluate the day-to-day diagnostic and therapeutic processes of AFib ablation in Europe, is a prospective, multicentre, 12-month observational study which recruited 1410 patients from 10 different European countries.session webcastwebcast
  congress report 



ESC Congress 2012 in Munich
The Great East Japan Earthquake Disaster and Cardiovascular Diseasespress release

congress news

press release
 
Hiroaki 
SHIMOKAWA 
(Japan)
Refers to session:  Hot Line III: Late Breaking Trials on Arrhythmias and CAD presentation slides presentation slides

The Japanese earthquake and tsunami of 11 March 2011 has caused huge damage, including 15,861 dead and 3,018 missing persons, and, as of 6 June 2012, 388,783 destroyed homes. Following an investigation of the ambulance records made by doctors in the Miyagi prefecture, close to the epicentre of the earthquake and where the damage was greatest, cardiologists observations were made on the occurence and effects of five conditions.

conference webcastwebcast
  congress reports 



ESC Congress 2012 in Munich
CT angiography and perfusion to assess coronary artery disease: the CORE320 studypress release

congress news

press release
 
Joao A. C. LIMA (United States of America)Refers to session:  Hot Line III: Late Breaking Trials on Arrhythmias and CAD presentation slides presentation slides
A trial which evaluated the diagnostic accuracy of combined non-invasive CTA and CTP as compared with invasive angiography (ICA) and single photon computed tomography myocardial perfusion imaging (SPECT-MPI). Primary objective: to determine whether combined noninvasive CTA and CTP could reliably determine the presence or absence of flow limiting coronary stenoses as defined by the combination of ICA and SPECT-MPI. conference webcastwebcast
  congress report 



ESC Congress 2012 in Munich
Fractional Flow Reserve-Guided PCI Versus Medical Therapy in Stable Coronary Disease (The FAME 2 Trial)press release

congress news

press release
 
Bernard DE BRUYNE 
(Belgium)
Refers to session: Hot Line III: Late Breaking Trials on Arrhythmias and CAD presentation slides presentation slides
The FAME 2  trial was conducted to assess the role of FFR in the percutaneous treatment of stable coronary artery disease in one or more vessels.  The study enrolled 1220 patients with stable coronary artery disease, and compared clinical outcomes, safety and cost effectiveness of PCI guided by FFR plus optimal medical therapy (MT) with MT alone.session webcastwebcast
  congress report 



 
Press registration
2014
EuroPRevent
  8-10 May, Amsterdam
Heart Failure
  17-20 May, Athens
EuroPCR
  20-23 May, Paris
Cardiostim-EHRA 
  Europace
  18-21 June, Nice
Frontiers in 
  CardioVascular Biology

  4-6 July, Barcelona
ESC Congress
  30 Aug-3 Sep, Barcelona
Acute Cardiovascular Care
  18-20 Oct, Geneva
EuroEcho-Imaging
  3-6 Dec, Vienna


Receive My ESC News